This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Adoc Ssf, LLC, Pact Pharma, Inc.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Michael M Dubreuil: Innovator in Cancer Treatment
Introduction
Michael M Dubreuil is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Dubreuil is recognized for his work in developing advanced therapies aimed at combating cancer.
Latest Patents
Dubreuil's latest patents include groundbreaking compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy. His work focuses on compositions comprising and methods for the treatment of cancer using a neoTCR based cell therapy with a CD8 expression construct. These patents represent a significant advancement in the field of immunotherapy, providing new avenues for effective cancer treatment.
Career Highlights
Throughout his career, Michael M Dubreuil has worked with notable companies such as Adoc Ssf, LLC and Pact Pharma, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to the development of innovative cancer therapies.
Collaborations
Dubreuil has collaborated with esteemed colleagues, including Alex Franzusoff and Barbara Sennino. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer treatment methodologies.
Conclusion
Michael M Dubreuil's contributions to cancer treatment through his patents and collaborations highlight his dedication to innovation in the medical field. His work continues to inspire advancements in therapies that have the potential to change the lives of many patients.